Michael Thompson, MD, PhD, is board certified in hematology and oncology. He is an active clinical researcher whose interests include hematologic or blood cancers (lymphoma, myeloma, leukemia and myelodysplastic syndrome). He is also interested in developing new treatments for all cancers, particularly early phase (Phase I and II) molecular biomarker-driven clinical trials. Dr. Thompson is medical director for the Early Phase Cancer Research Program, Patient-Centered Research at the Aurora Research Institute. He is extensively published and serves as a reviewer for multiple scientific publications.